Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response of Somatropin in Turner Syndrome
NCT01518062Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 1989
- Primary completion
- Sep 2003
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in Turner syndrome (TS), sponsored by Novo Nordisk. Started Nov 1989; status: completed.
02
Drugs
somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT01518062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518062.